A case is described of progressive multifocal leukoencephalopathy (PML) occurring in a man with myelodysplastic syndrome type II (MDS II) and prostatic carcinoma. This is the first case, to our knowledge, of the association of PML with MDS II.
Introduction
Progressive multifocal leukoencephalopathy (PML) is a rare progressive demyeinating disease which is difficult to diagnose in life without a high index of suspicion. Thus it is important to delineate the conditions with which it is associated. There are reports of its association with widespread carcinomatosis but not of its association with myelodysplastic syndrome II (MDS II).
Case report
An 82-year-old retired fishmonger was referred with a 2-week history of gradual onset of left-sided weakness. He had become incontinent of urine and forgetful. His past medical history was unremarkable apart from pain from a right osteo-arthritic hip for which he took phenylbutazone. General examination showed fast atrial fibrillation (110 per min) and blood pressure 150/90 mmHg. He was not in heart failure. Rectal examination revealed a firm, enlarged prostate gland. He had a left hemiparesis with weakness more marked in the leg than the arm. Mental testing revealed him to be fully orientated and to have a good recent memory. He was mildly anaemic (haemoglobin 9-6 g/dl) with normal red cell indices, the erythrocyte sedimentation rate was 46 mm. The serum acid phosphatase was high at 31-0 u/litre and he was folate deficient with serum levels on two occasions of 0-2 and l 0 pg/litre (ng/ml (Fig.  1 ). In addition, there was a moderately differentiated adenocarcinoma of the prostate which had invaded lymph nodes within the pelvis but had not extended beyond the pelvis.
Discussion
PML is a rare, progressive disease of the central nervous system (CNS) thought to be induced by papova viruses and occurring predominantly in immunocompromised patients. It has been reported in patients with lymphoproliferative and myeloproliferative neoplasms, carcinomatosis, chronic granulomatous disease but only occasionally in patients with no proven chronic disorder (Richardson, 1974) .
Papova viruses have been identified in the CNS lesions by electron microscopy and fluorescent antibody techniques and isolated from the lesions in tissue culture. (Editorial, 1972; Narayan et al., 1973 MDS II gives a chronic refractory anaemia with dyserythropoiesis and pathological sideroblastic change in the marrow. Growing interest in the syndromes of marrow dysplasia and pre-leukaemia has led to a recent classification by the French/American/British Group (Bennett et al., 1982) . This form of acquired sideroblastic anaemia has been described in association with malignancy without the bone marrow but is most often a primary disorder which may be pre-leukaemic. The one published case (Allergranza et al. 1981) 
